Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Asselain

Showing results (61-70 of 227) with videos related to

Pageof 23
Sort By:
Cancer|January 15, 1996
Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapyS Chevillard, P Pouillart, C Beldjord, et al.
Clinical and Experimental Immunology|February 1, 1992
Increased levels of soluble low-affinity Fc gamma receptors (IgG-binding factors) in the sera of tumour-bearing miceA Lynch, E Tartour, J L Teillaud, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 8, 2009
Patient experiences and preferences: development of practice guidelines in a cancer imaging departmentL Ollivier, F Apiou, J Leclère, et al.
British Journal of Cancer|June 1, 1992
Cyclical mastalgia as a marker of breast cancer susceptibility: results of a case-control study among French womenG Plu-Bureau, J C Thalabard, R Sitruk-Ware, et al.
Breast Cancer Research and Treatment|October 17, 1998
Estrogen receptor negative and progesterone receptor positive primary breast cancer: pathological characteristics and clinical outcome. Institut Curie Breast Cancer Study GroupA Bernoux, P de Cremoux, C Lainé-Bidron, et al.
British Journal of Cancer|February 13, 2008
Second malignancies after breast cancer: the impact of different treatment modalitiesY M Kirova, Y De Rycke, L Gambotti, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1988
Primary radiotherapy of squamous cell carcinoma of the oropharynx and pharyngolarynx: tentative multivariate modelling system to predict the radiocurability of neck nodesJ P Bataini, J Bernier, B Asselain, et al.
Bulletin Du Cancer|January 1, 1984
[Metastatic breast cancer: controlled trial of chemotherapy with and without hormones]M Jouve, T Palangie, E Garcia-Giralt, et al.
Cancer Genetics and Cytogenetics|December 22, 1999
TP53 status and gene amplification in human colorectal carcinomasP Soulié, E Fourme, R Hamelin, et al.
Bulletin Du Cancer|January 1, 1984
[Metastatic breast cancer: controlled treatment trial of chemotherapy combined with hormone therapy using medroxyprogesterone alone or combined with tamoxifen]M Jouve, T Palangie, B Bretaudeau, et al.
Pageof 23

Showing results (61-70 of 227) with videos related to

Sort By:
Pageof 23
Cancer|January 15, 1996
Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapyS Chevillard, P Pouillart, C Beldjord, et al.
Clinical and Experimental Immunology|February 1, 1992
Increased levels of soluble low-affinity Fc gamma receptors (IgG-binding factors) in the sera of tumour-bearing miceA Lynch, E Tartour, J L Teillaud, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 8, 2009
Patient experiences and preferences: development of practice guidelines in a cancer imaging departmentL Ollivier, F Apiou, J Leclère, et al.
British Journal of Cancer|June 1, 1992
Cyclical mastalgia as a marker of breast cancer susceptibility: results of a case-control study among French womenG Plu-Bureau, J C Thalabard, R Sitruk-Ware, et al.
Breast Cancer Research and Treatment|October 17, 1998
Estrogen receptor negative and progesterone receptor positive primary breast cancer: pathological characteristics and clinical outcome. Institut Curie Breast Cancer Study GroupA Bernoux, P de Cremoux, C Lainé-Bidron, et al.
British Journal of Cancer|February 13, 2008
Second malignancies after breast cancer: the impact of different treatment modalitiesY M Kirova, Y De Rycke, L Gambotti, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1988
Primary radiotherapy of squamous cell carcinoma of the oropharynx and pharyngolarynx: tentative multivariate modelling system to predict the radiocurability of neck nodesJ P Bataini, J Bernier, B Asselain, et al.
Bulletin Du Cancer|January 1, 1984
[Metastatic breast cancer: controlled trial of chemotherapy with and without hormones]M Jouve, T Palangie, E Garcia-Giralt, et al.
Cancer Genetics and Cytogenetics|December 22, 1999
TP53 status and gene amplification in human colorectal carcinomasP Soulié, E Fourme, R Hamelin, et al.
Bulletin Du Cancer|January 1, 1984
[Metastatic breast cancer: controlled treatment trial of chemotherapy combined with hormone therapy using medroxyprogesterone alone or combined with tamoxifen]M Jouve, T Palangie, B Bretaudeau, et al.
Pageof 23